Sabra Healthcare REIT, Inc.

SBRA Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.

Revenue
+31.3%
EPS
+24.1%
Free cash flow
+26.7%
Total debt
−5.99%

Quarter to September 2026, against a year earlier

21.05 0.16 +0.77%
Market cap
$5.5B
P/E
74.7×
Fwd P/E
48.8×
Dividend yield
5.70%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Sabra Healthcare REIT, Inc. (SBRA) EBITDA

Alert me on EBITDA

Sabra Healthcare REIT, Inc.'s EBITDA for fiscal 2025 was $443.5M, up 8.66% from $408.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $389.3M. Over the past ten years it has ranged from $200.3M (fiscal 2015) to $496.3M (fiscal 2018); the current reading is higher than 91% of that period. EBITDA has risen for 3 consecutive fiscal years. Sabra Healthcare REIT, Inc. ranks 9th of 17 Reit Healthcare Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $443.5M 8.66%
FY2024 $408.2M 4.59%
FY2023 $390.3M 18.83%
FY2022 $328.4M (13.62%)
FY2021 $380.2M (11.24%)
FY2020 $428.4M 7.28%
FY2019 $399.3M (19.54%)
FY2018 $496.3M 60.44%
FY2017 $309.3M 54.20%
FY2016 $200.6M 0.13%

Quarterly newest first

Period EBITDA Change
Sep 2026 $128.7M 428.78%
Jun 2026 $24.3M (79.90%)
Mar 2026 $121.0M 4.93%
Dec 2025 $115.3M 9.33%
43 more quarters

Against its own ten years

Low $200.3M High $496.3M
Ten-year median $390.3M
Current reading's percentile 91

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on SBRA